Dingdang Health logs fresh buyback of 171,000 shares; cumulative repurchases reach 64.99 million, or 4.93% of mandate

Bulletin Express05-19

Dingdang Health Technology Group Ltd. disclosed that it repurchased 171,000 ordinary shares on 19 May 2026 via on-market transactions at prices ranging from HKD 0.94 to HKD 0.98, for a total consideration of HKD 0.16 million.

Including this latest tranche, the company has acquired 64.99 million shares under the repurchase mandate approved on 28 May 2025. The cumulative volume represents 4.93% of the 1.32 billion shares that were outstanding on the mandate date, utilising almost half (49.27%) of the authorised 131.95 million-share limit.

All 64.99 million repurchased shares, together with the new 171,000 shares, are earmarked for cancellation. As of 19 May 2026, the company’s issued share capital stood unchanged at 1.32 billion shares, pending the formal cancellation of the repurchased stock.

A 30-day moratorium on new share issues or treasury-share sales is in effect until 18 June 2026, in accordance with Hong Kong listing rules governing buybacks.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1100102896?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-19 18:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100102896","market":"us","top_or_hot":-1,"title":"Dingdang Health logs fresh buyback of 171,000 shares; cumulative repurchases reach 64.99 million, or 4.93% of mandate","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group Ltd. disclosed that it repurchased 171,000 ordinary shares on 19 May 2026 via on-market transactions at prices ranging from HKD 0.94 to HKD 0.98, for a total consideration of HKD 0.16 million.</p>\n<p>Including this latest tranche, the company has acquired 64.99 million shares under the repurchase mandate approved on 28 May 2025. The cumulative volume represents 4.93% of the 1.32 billion shares that were outstanding on the mandate date, utilising almost half (49.27%) of the authorised 131.95 million-share limit.</p>\n<p>All 64.99 million repurchased shares, together with the new 171,000 shares, are earmarked for cancellation. As of 19 May 2026, the company’s issued share capital stood unchanged at 1.32 billion shares, pending the formal cancellation of the repurchased stock.</p>\n<p>A 30-day moratorium on new share issues or treasury-share sales is in effect until 18 June 2026, in accordance with Hong Kong listing rules governing buybacks.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health logs fresh buyback of 171,000 shares; cumulative repurchases reach 64.99 million, or 4.93% of mandate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health logs fresh buyback of 171,000 shares; cumulative repurchases reach 64.99 million, or 4.93% of mandate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-19 18:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group Ltd. disclosed that it repurchased 171,000 ordinary shares on 19 May 2026 via on-market transactions at prices ranging from HKD 0.94 to HKD 0.98, for a total consideration of HKD 0.16 million.</p>\n<p>Including this latest tranche, the company has acquired 64.99 million shares under the repurchase mandate approved on 28 May 2025. The cumulative volume represents 4.93% of the 1.32 billion shares that were outstanding on the mandate date, utilising almost half (49.27%) of the authorised 131.95 million-share limit.</p>\n<p>All 64.99 million repurchased shares, together with the new 171,000 shares, are earmarked for cancellation. As of 19 May 2026, the company’s issued share capital stood unchanged at 1.32 billion shares, pending the formal cancellation of the repurchased stock.</p>\n<p>A 30-day moratorium on new share issues or treasury-share sales is in effect until 18 June 2026, in accordance with Hong Kong listing rules governing buybacks.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1100102896","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100102896","pubTimestamp":1779187407,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group Ltd. disclosed that it repurchased 171,000 ordinary shares on 19 May 2026 via on-market transactions at prices ranging from HKD 0.94 to HKD 0.98, for a total...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康新回购17.1万股；累计回购达6499万笔，占授权的4.93%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group Ltd. disclosed that it repurchased 171,000 ordinary shares on 19 May 2026 via on-market transactions at prices ranging from HKD 0.94 to HKD 0.98, for a total consideration of HKD 0.16 million.\nIncluding this latest tranche, the company has acquired 64.99 million shares under the repurchase mandate approved on 28 May 2025. The cumulative volume represents 4.93% of the 1.32 billion shares that were outstanding on the mandate date, utilising almost half (49.27%) of the authorised 131.95 million-share limit.\nAll 64.99 million repurchased shares, together with the new 171,000 shares, are earmarked for cancellation. As of 19 May 2026, the company’s issued share capital stood unchanged at 1.32 billion shares, pending the formal cancellation of the repurchased stock.\nA 30-day moratorium on new share issues or treasury-share sales is in effect until 18 June 2026, in accordance with Hong Kong listing rules governing buybacks.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1100102896","isCrawlerRequest":true}